SEC Form 4 · accession 0001140361-16-063730
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C Farrell
Director
Period of report
May 4, 2016
Accepted (ET)
May 6, 2016 · 12:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | May 4, 2016 | M | 20,000 | $25.54 | A | 367,978 | D | |
| ResMed Common StockF3 | May 4, 2016 | S | 20,000 | $55.90 | D | 347,978 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Stock Option PlanF2 | $25.54 | May 4, 2016 | M | 20,000 | D | Dec 17, 2010 | Dec 17, 2016 | ResMed Common Stock | 20,000 | 96,085 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.
- F2Represents date options first became exercisable. Options vested 1/4 per year.
- F3This transaction was executed in multiple trades at prices ranging from 55.64 to 56.22. The price reported above represents the weighted average sales price.